Wang H J, Kim J H, Kim J H, Kim W H, Kim M W
Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
Hepatogastroenterology. 1999 Jul-Aug;46(28):2495-9.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC), presenting as obstructive jaundice caused by tumor thrombi in the bile duct, is rare. The authors report on clinical experiences and evaluate the results of different treatment modalities for this disease.
We experienced 549 cases of HCC at Ajou University Hospital from June 1994 through January 1998. Among them, 10 cases with gross evidence of tumor thrombi in the bile duct were treated with different resection methods and interventions, and then compared with those receiving short-term results.
Eight out of 10 patients underwent exploratory laparotomy: right lobectomy with extrahepatic bile duct resection in 2 cases; right lobectomy with tumor thrombectomy in 2 cases; left lobectomy and caudate lobectomy with extra-hepatic bile duct resection in 2 cases: T-tube drainage in 1 case and biopsy only with post-operative internal biliary stent, in 1 case. Survival times of these patients were 39 months (still alive); 38 months (still alive); 8 months (died); 8 months (died); 8 months (still alive); 1 month (still alive); 14 months (died); 8 months (died), respectively. Of the 2 non-surgical cases, 1 underwent PTBD only and the other had endoscopic removal of the thrombi. Their survival times were 18 days (died) and 24 months (still alive with recurrence), respectively. The 4 cases, with right lobectomy or left lobectomy including extrahepatic bile duct resection, had relatively long-term disease-free survival (39 months, 38 months, 8 months and 1 month after operation, respectively). However, there were no differences in survival between the partial hepatectomy procedure with removal of tumor thrombi and the simple drainage procedure without tumor resection.
Although the number of patients in this study is small, our results suggest that: 1) For the improvement of survival, it seems necessary to perform major hepatic resection with removal of the extrahepatic bile duct. 2) If hepatic resection cannot be accomplished with bile duct resection due to limited liver function, non-surgical modalities should be considered instead of surgery because no differences in prognosis between the 2 groups exist.
背景/目的:肝细胞癌(HCC)表现为胆管内肿瘤血栓导致的梗阻性黄疸,较为罕见。作者报告临床经验并评估该疾病不同治疗方式的结果。
1994年6月至1998年1月,我们在阿朱大学医院共诊治549例HCC患者。其中,10例有明显胆管内肿瘤血栓证据的患者接受了不同的切除方法和干预措施,然后与接受短期治疗的患者进行比较。
10例患者中有8例行剖腹探查术:2例行右叶切除术加肝外胆管切除术;2例行右叶切除术加肿瘤血栓切除术;2例行左叶切除术和尾状叶切除术加肝外胆管切除术;1例行T管引流术;1例仅行活检并术后放置胆道内支架。这些患者的生存时间分别为39个月(仍存活);38个月(仍存活);8个月(死亡);8个月(死亡);8个月(仍存活);1个月(仍存活);14个月(死亡);8个月(死亡)。2例非手术治疗的患者中,1例仅接受经皮经肝胆道引流术(PTBD),另1例行内镜下血栓清除术。他们的生存时间分别为18天(死亡)和24个月(仍存活但复发)。4例行右叶切除术或左叶切除术加肝外胆管切除术的患者有相对较长的无病生存期(分别在术后39个月、38个月、8个月和1个月)。然而,切除肿瘤血栓的部分肝切除术与未切除肿瘤的单纯引流术在生存率上并无差异。
尽管本研究中的患者数量较少,但我们的结果表明:1)为提高生存率,似乎有必要行肝大部切除术并切除肝外胆管。2)如果由于肝功能受限无法在切除胆管的同时进行肝切除术,则应考虑非手术治疗而非手术治疗,因为两组的预后无差异。